KALA BIO, Inc. Stock Analysis & AI Score
KALA BIO, Inc. (KALA) has an ST Score of 45.3 (C+), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Hold with a $18.25 price target (+3158.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
KALA BIO, Inc. (KALA) has an ST Score of 45.3 (C+), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Hold with a $18.25 price target (+3158.9% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- Financial StrengthB+
- GrowthB
- ValuationC
- MomentumD
- ProfitabilityF
- Piotroski3/9
Contact
KALA stock: frequently asked questions
What is KALA's ST Score?
KALA BIO, Inc. (KALA) has an ST Score of 45.3 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is KALA a buy, hold, or sell?
Analysts rate KALA a Hold, with a price target of $18.25 (+3158.9% vs the current price). Our ST Score grades it C+ (45.3/100). The ST Score is a data-driven signal, not a recommendation.
What are KALA's factor grades?
Valuation C, Profitability F, Financial Strength B+, Momentum D, Growth B, Forecast A.
What is KALA's valuation grade?
KALA BIO, Inc. (KALA) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is KALA's growth grade?
KALA BIO, Inc. (KALA) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is KALA's profitability grade?
KALA BIO, Inc. (KALA) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is KALA's financial strength grade?
KALA BIO, Inc. (KALA) earns a financial strength grade of B+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for KALA?
The average analyst price target for KALA BIO, Inc. (KALA) is $18.25 from 11 analysts, which is +3158.9% versus the recent price of $0.56.
What is KALA's Piotroski score?
KALA BIO, Inc. (KALA) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.